Navigation Links
Leeches Provide Clues Regarding The Prevention Of Heart Disease

Cardiovascular diseases have now become common place owing to the wide scale industrialization and subsequent// change in life style. Time and over again, scientists have been working on ways to prevent or treat heart ailments without surgical intervention. The results of a recent research have recently confirmed that leeches could be used in the treatment of cardiovascular diseases.

The leeches have added to the biomedical interest by showing that it contains an extensive list of new potential molecules that may become useful tools. There has been an increasing tendency to turn towards blood-feeding invertebrates as a source for drugs and lead compounds to treat cardiovascular disease because these animals have evolved highly efficient mechanisms to feed on their hosts by blocking blood coagulation.

Most heart attacks and strokes are associated with a blocked artery and in a majority of the cases; blood clots may cause the blockage of blood vessels supplying the heart, leading to heart disease. Furthermore, people with cardiovascular disease typically have an increased tendency to form blood clots, and a decreased ability to dissolve clots before they can do any damage. Therefore, compounds interrupting the blood coagulation cascade may inhibit thrombus development as well.

The researchers have identified and analyzed peptides and small proteins in the saliva of the medical leech Hirudo medicinalis for their ability to bind to molecules called serine proteases. These molecules have the ability to prevent coagulation or clotting of blood.

Of the nearly 2,000 molecules the researches screened, more than 75 of them interacted specifically with the fixed target and 16 of these binding molecules were isolated and subsequently characterized as new inhibitors that had potential to be used as drugs in treating cardiovascular disease.

Although these newly discovered molecules are a long way from being used to treat cardiovasc ular disease, they do represent several important leads in the search for more effective anticoagulant and fibrinolytic drugs. The research tem has also expressed interest towards screening of different types of leeches and other blood sucking animals for their anti-coagulant potential.

Medindia on chest pain:

Some causes of chest pain require prompt medical attention, such as angina, heart attack, or tearing of the aorta. Other causes of chest pain can be evaluated electively, such as spasm of the esophagus, gallbladder attack, or inflammation of the chest wall.
'"/>




Related medicine news :

1. Leeches help in tissue transfer
2. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
3. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
4. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
5. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
6. Reindeer Provide Valuable Insights Into Sleep Disorders
7. London Hospital Provides Specialized Care For Pregnant Women
8. CNIC To Provide Funds To Mount Sinai School
9. Clean Blades To Be Provided To Self-Harmers
10. Breastfeeding Provides Added Protection To Babies
11. Court Orders Private Hospitals To Provide Free Treatment For The Poor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2016)... ... May 30, 2016 , ... Shaolin ... warrior 8-day-8 and 8-night special intensive summer training camp starts on June 17th ... camp offers families and children a fun and unique experience with an opportunity ...
(Date:5/29/2016)... ... May 29, 2016 , ... "With 30 unique self-animating ... user control the style of their project," said Christina Austin - CEO of Pixel ... web-themed intros created exclusively for use in Final Cut Pro X. Pixel Film Studios’ ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide ... we as a society can control and change. , As nearly 795,000 Americans suffering ... seconds within the United States. Plus, with an estimated 129,000 of these people dying ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
Breaking Medicine Technology: